Charting a pathway to follow-on biologics

被引：0
|
作者：
Greb, Erik
机构：
来源：
Pharmaceutical Technology | 2009年 / 33卷 / 06期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：36 / 42
相关论文
共 50 条
  • [31] A Tolerance Interval Approach to Assessing the Biosimilarity of Follow-On Biologics
    Chen, Chi-Tian
    Tsou, Hsiao-Hui
    Hsiao, Chin-Fu
    Lai, Yi-Hsuan
    Chang, Wan-Jung
    Liu, Jung-Tzu
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2017, 9 (03): : 286 - 292
  • [32] 'Generic' or 'follow-on" biologics: scientific considerations and safety issues
    Green, JD
    Tsang, L
    Cavagnaro, JA
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2003, 3 (07) : 1019 - 1022
  • [33] Nonparametric Tests for Evaluation of Biosimilarity in Variability of Follow-on Biologics
    Zhang, Nan
    Yang, Jun
    Chow, Shein-Chung
    Chi, Eric
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2014, 24 (06) : 1239 - 1253
  • [34] 'Follow-on biologics': Ensuring continued innovation in the biotechnology industry
    Manheim, BS
    Granahan, P
    Dow, KJ
    HEALTH AFFAIRS, 2006, 25 (02) : 394 - 404
  • [35] Follow-on biologics in oncology - the need for global and local regulations
    Hus, Iwona
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2012, 16 (06): : 461 - 466
  • [36] Statistical Test for Evaluation of Biosimilarity in Variability of Follow-On Biologics
    Hsieh, Tsung-Cheng
    Chow, Shein-Chung
    Liu, Jen-pei
    Hsiao, Chin-Fu
    Chi, Eric
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2010, 20 (01) : 75 - 89
  • [37] Follow-on biologics: data exclusivity and the balance between innovation and competition
    Henry Grabowski
    Nature Reviews Drug Discovery, 2008, 7 : 479 - 488
  • [38] Global follow-on biologics - IBC's fifth annual conference
    Wheelwright, Scott M.
    IDRUGS, 2008, 11 (02) : 94 - 96
  • [39] BIOT 174-Scientific developments in the follow-on biologics debate
    Moreira, Antonio R.
    Hanson, Michael A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232
  • [40] Emerging Experience with Follow-On Biologics: Active Surveillance and Risk Management
    Morris, Jon
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S267 - S267
12345